Cargando…
Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy
Photodynamic therapy (PDT) is a treatment option for pachychoroid diseases such as central serous chorioretinopathy (CSC), pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy (PCV), and peripapillary pachychoroid syndrome (PPS). On the other hand, morphological changes of choroidal...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352534/ https://www.ncbi.nlm.nih.gov/pubmed/35935116 http://dx.doi.org/10.7759/cureus.27663 |
_version_ | 1784762668683362304 |
---|---|
author | Yamada, Chizu Mukai, Ryo Shinohara, Yoichiro Matsumoto, Hidetaka Akiyama, Hideo |
author_facet | Yamada, Chizu Mukai, Ryo Shinohara, Yoichiro Matsumoto, Hidetaka Akiyama, Hideo |
author_sort | Yamada, Chizu |
collection | PubMed |
description | Photodynamic therapy (PDT) is a treatment option for pachychoroid diseases such as central serous chorioretinopathy (CSC), pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy (PCV), and peripapillary pachychoroid syndrome (PPS). On the other hand, morphological changes of choroidal vessels in the irradiated field after PDT have also been discussed, with occlusion of choriocapillaris and stenosis of choroidal middle and large vessels being reported. Here, we report a case of vortex vein occlusion after half-fluence PDT (HF-PDT) combined with an anti-vascular endothelial growth factor (VEGF) agent for PNV. In this case, HF-PDT achieved complete occlusion of PNV; in addition, a vortex vein that flowed in PNV but was located outside the PDT irradiation field was fully occluded three months post-treatment. At the occluded site of the vortex vein, indocyanine green video angiography revealed pulsation downstream of the vortex vein. Such occlusion of a large vessel by HF-PDT has not been reported previously. Occlusion could be induced by two factors: the potentiality of PDT and risk factors for thromboembolism, such as older age, smoking, and arrhythmia. Further studies are required to determine the mechanisms of these large vessel occlusions. |
format | Online Article Text |
id | pubmed-9352534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-93525342022-08-05 Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy Yamada, Chizu Mukai, Ryo Shinohara, Yoichiro Matsumoto, Hidetaka Akiyama, Hideo Cureus Ophthalmology Photodynamic therapy (PDT) is a treatment option for pachychoroid diseases such as central serous chorioretinopathy (CSC), pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy (PCV), and peripapillary pachychoroid syndrome (PPS). On the other hand, morphological changes of choroidal vessels in the irradiated field after PDT have also been discussed, with occlusion of choriocapillaris and stenosis of choroidal middle and large vessels being reported. Here, we report a case of vortex vein occlusion after half-fluence PDT (HF-PDT) combined with an anti-vascular endothelial growth factor (VEGF) agent for PNV. In this case, HF-PDT achieved complete occlusion of PNV; in addition, a vortex vein that flowed in PNV but was located outside the PDT irradiation field was fully occluded three months post-treatment. At the occluded site of the vortex vein, indocyanine green video angiography revealed pulsation downstream of the vortex vein. Such occlusion of a large vessel by HF-PDT has not been reported previously. Occlusion could be induced by two factors: the potentiality of PDT and risk factors for thromboembolism, such as older age, smoking, and arrhythmia. Further studies are required to determine the mechanisms of these large vessel occlusions. Cureus 2022-08-04 /pmc/articles/PMC9352534/ /pubmed/35935116 http://dx.doi.org/10.7759/cureus.27663 Text en Copyright © 2022, Yamada et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Ophthalmology Yamada, Chizu Mukai, Ryo Shinohara, Yoichiro Matsumoto, Hidetaka Akiyama, Hideo Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy |
title | Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy |
title_full | Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy |
title_fullStr | Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy |
title_full_unstemmed | Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy |
title_short | Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy |
title_sort | occlusion of a vortex vein after treatment with half-fluence photodynamic therapy combined with intravitreal aflibercept injection for pachychoroid neovasculopathy |
topic | Ophthalmology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352534/ https://www.ncbi.nlm.nih.gov/pubmed/35935116 http://dx.doi.org/10.7759/cureus.27663 |
work_keys_str_mv | AT yamadachizu occlusionofavortexveinaftertreatmentwithhalffluencephotodynamictherapycombinedwithintravitrealafliberceptinjectionforpachychoroidneovasculopathy AT mukairyo occlusionofavortexveinaftertreatmentwithhalffluencephotodynamictherapycombinedwithintravitrealafliberceptinjectionforpachychoroidneovasculopathy AT shinoharayoichiro occlusionofavortexveinaftertreatmentwithhalffluencephotodynamictherapycombinedwithintravitrealafliberceptinjectionforpachychoroidneovasculopathy AT matsumotohidetaka occlusionofavortexveinaftertreatmentwithhalffluencephotodynamictherapycombinedwithintravitrealafliberceptinjectionforpachychoroidneovasculopathy AT akiyamahideo occlusionofavortexveinaftertreatmentwithhalffluencephotodynamictherapycombinedwithintravitrealafliberceptinjectionforpachychoroidneovasculopathy |